Lundbeck delivers 22 percent revenue growth for 2009
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Bristol-Myers Squibb and Allergan Enter Global Agreement
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Anavex comments on failure of Pfizer and Medivation's Alzheimer's Investigational drug Dimebon
- Details
- Category: Clinical Trials
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) issued a statement following the announcement from Pfizer and Medivation (NASDAQ:MDVN) that their investigational Alzheimer's drug Dimebon did not meet either its co-primary or secondary endpoints compared to placebo during pivotal Phase 3 clinical trials.
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Novo Nordisk receives FDA approval for Norditropin® FlexPro® for growth hormone treatment
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
FDA Advisory Committee Recommends Approval of Belatacept
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Initiation of Phase 2 Clinical Trial Investigating Three Individual HCV Antivirals
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
More Pharma News ...
- Nycomed on track in 2009 with strong growth in Key Products
- GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia
- Phase III study of Avastin in advanced stomach cancer did not meet primary endpoint
- Pfizer's Prevnar 13 Recommended by CDC's Advisory Committee On Immunization Practices
- FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
- Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc.
- Novartis receives FDA approval of Menveo®